Navigation Links
MedNet Solutions Proudly Welcomes Accelovance To The iMedNet Partner Program
Date:9/26/2013

MINNETONKA, Minn., Sept. 26, 2013 /PRNewswire/ -- MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Accelovance, an award-winning, full-service clinical research organization (CRO) focused in early phase Oncology, Vaccines and General Medicine development, has joined the iMedNet Partner Program.    Designation as an iMedNet Partner will facilitate Accelovance's ability to offer iMedNet EDC to clients as an advanced solution for the data management needs associated with clinical trial programs while providing significant cost savings compared with similar platforms. 

"MedNet is extremely pleased to partner with Accelovance, a recognized industry leader," remarked John M. (Rob) Robertson, President and CEO of MedNet Solutions. "Given their well-documented track record of continuously reducing study costs and timelines, their selection of iMedNet EDC to further improve study efficiency is a major testament to the tremendous benefits that iMedNet can deliver.  We look forward to working side-by-side with this growing organization and meeting their eClinical needs for many years to come."

"The adoption of the iMedNet technology further expands the breadth of available solutions within our data management offering.  We believe this is an attractive option for Sponsors having an early phase concentration and a desire to utilize a state of the art eClinical solution to enhance study efficiencies while maintaining budget discipline," noted Steve Trevisan, President and CEO of Accelovance.

Accelovance's focus on providing the best fit solutions and operational expertise has been a key driver in the growth trajectory of the company.  With their acquisition of Radiant Research to bolster their General Medicine experience, continued leadership position in the conduct of Vaccine trials, and key additions to their scientific and operational Oncology staff, they continue on a path of significant expansion.

Please contact MedNet Solutions for more information on iMedNet EDC or the iMedNet Partner Program, and Accelovance for additional details on their comprehensive lineup of clinical research services.

Stay in touch with MedNet:

About MedNet Solutions

MedNet Solutions is a leading healthcare technology company specializing in electronic data capture (EDC) and clinical trial management systems (CTMS) designed for the global life sciences market.  MedNet delivers proven, flexible and easy-to-use web-based eClinical solutions that effectively support clinical studies, registries and investigator initiated trials of all types and sizes.  Since 2001, MedNet has successfully supported pharmaceutical, medical device, biotechnology and contract research organizations (CROs) on clinical research conducted around the world.  These companies trust MedNet to consistently deliver the technology innovation, experience and reliability they need for success.  For more information, please visit www.mednetstudy.com.

About Accelovance

Headquartered in Rockville, Maryland, Accelovance is a privately held company that has developed a unique operational approach for delivering quality, on time, and cost effective clinical studies. The company was recognized as "Best CRO" with consecutive Industry Excellence awards in 2009, 2010 and 2011. Accelovance tailors its full offering of CRO services to present a clinical solution that meets a sponsor's needs. Accelovance has a 100% owned subsidiary providing CRO services in China. These capabilities can assist clients with global development programs or product registration in China, the fastest growing pharmaceutical market in the world.  For more information, visit the company's website at www.accelovance.com or follow them on Twitter at www.twitter.com/Accelovance.

Contact Information:
Dirk H. Nelson
Director of Marketing
MedNet Solutions
110 Cheshire Lane, Suite 300
Minnetonka, MN  55305
USA
(763) 258-2735

Michael Keens
Vice President, Sales & Marketing
Accelovance, Inc.
2275 Research Blvd, Suite 700
Rockville, MD  20850
USA
(240) 238-4941


'/>"/>
SOURCE MedNet Solutions
Copyright©2012 PR Newswire.
All rights reserved

Related biology news :

1. MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
2. MedNet Solutions Announces Latest Enhancements To Its iMedNet EDC eClinical Solution
3. Statistics & Data Corporation Selects MedNet Solutions As Strategic Technology Partner
4. Advanced Clinical Joins MedNet Solutions iMedNet Partner Program
5. MedNet Solutions To Feature iMedNet EDC At The 2013 SCOPE Conference
6. MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting
7. Advance Research Associates Partners With MedNet Solutions
8. MedNet Solutions To Sponsor The SCDM Annual Conference For The Eighth Straight Year
9. Bowman provides strategies to engage public with climate change solutions
10. University of Minnesota startup offers game-changing energy solutions that reduce CO2 emissions
11. BioLife Solutions Announces 7th Consecutive Quarter of Record Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2016)... , June 20, 2016 Securus ... justice technology solutions for public safety, investigation, corrections ... the prisons involved, it has secured the final ... (DOC) facilities for Managed Access Systems (MAS) installed. ... additional facilities to be installed by October, 2016. ...
(Date:6/9/2016)... 2016  Perkotek an innovation leader in attendance control systems is proud to announce ... for employers to make sure the right employees are actually signing in, and to ... ... ... ...
(Date:6/3/2016)... 3, 2016 Das ... Nepal hat ein 44 ... geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und IT-Infrastruktur, ... Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte ... Januar teilgenommen, aber Decatur wurde als konformste ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... to announce the launch of their brand, UP4™ Probiotics, into Target stores nationwide. ... years, is proud to add Target to its list of well-respected retailers. This ...
(Date:6/23/2016)... TORONTO , June 23, 2016 /PRNewswire/ - ... Ontario biotechnology company, Propellon ... the development and commercialization of a portfolio of ... cancers. Epigenetic targets such as WDR5 represent an ... contribute significantly in precision medicine for cancer patients. ...
Breaking Biology Technology: